×
About 188 results

ALLMedicine™ Guttate Psoriasis Center

Research & Reviews  56 results

Guselkumab Immunogenetics
https://clinicaltrials.gov/ct2/show/NCT04645355

May 2nd, 2022 - Guselkumab (Tremfya®), an IL-23 inhibitor approved for the treatment of moderate-to-severe plaque psoriasis. Given the potential role of IL-23 in the pathogenesis of guttate psoriasis, guselkumab may be an effective option to treat the initial man...

COVID-19 infection linked to risk of cutaneous autoimmune and vascular diseases
https://www.mdedge.com/dermatology/article/253200/autoimmune-diseases/covid-19-infection-linked-risk-cutaneous-autoimmune
Doug Brunk

Mar 26th, 2022 - BOSTON – Following infection with SARS-CoV-2 infection, patients between the ages of 18 and 65 were at a significantly increased for developing certain cutaneous autoimmune and vascular diseases. This predominately favored systemic disease states.

Guttate Psoriasis Following COVID-19 Infection
https://www.mdedge.com/dermatology/article/251436/psoriasis/guttate-psoriasis-following-covid-19-infection
Rucha P. Janodia, BA, Erine A. Kupetsky, DO, MSc

Feb 4th, 2022 - Psoriasis is an inflammatory skin condition affecting 1% to 5% of the world population. 1 Guttate psoriasis is a subgroup of psoriasis that most commonly presents as raindroplike, erythematous, silvery, scaly papules.

The histologic and molecular correlates of COVID-19 vaccine-induced changes in the skin.
https://doi.org/10.1016/j.clindermatol.2021.07.011
Clinics in Dermatology; Magro C, Crowson AN et. al.

Dec 19th, 2021 - A total of 22 patients who had developed an adverse cutaneous reaction to the Moderna or Pfizer vaccine underwent biopsies. Each patient was assessed light microscopically, and, in select biopsies, spike glycoprotein and cytokine assessment were a...

Ichthyosis, psoriasiform dermatitis, and recurrent fungal infections in patients with b...
https://doi.org/10.1111/jdv.17856
Journal of the European Academy of Dermatology and Venere... Youssefian L, Khodavaisy S et. al.

Dec 5th, 2021 - Germline autosomal dominant and autosomal recessive mutations in PERP, encoding p53 effector related to PMP-22 (PERP), a component of epidermal desmosomes, have been associated with a spectrum of keratodermas. Monoallelic nonsense mutations cause ...

see more →

Clinicaltrials.gov  4 results

Guselkumab Immunogenetics
https://clinicaltrials.gov/ct2/show/NCT04645355

May 2nd, 2022 - Guselkumab (Tremfya®), an IL-23 inhibitor approved for the treatment of moderate-to-severe plaque psoriasis. Given the potential role of IL-23 in the pathogenesis of guttate psoriasis, guselkumab may be an effective option to treat the initial man...

MED in UVB Devices in the Presence and Absence of UV Filter
https://clinicaltrials.gov/ct2/show/NCT03049319

Aug 29th, 2019 - Psoriasis affects 2-3% of the American population. Psoriasis involving less than 10% BSA in the absence of joint involvement tends to be treated locally. More than 80% of people with psoriasis have <10% BSA involvement. A wide variety of therapies...

Bicillin L-A vs Placebo for the Treatment of Chronic, Plaque-Type Psoriasis Unresponsive to Topical Medications
https://clinicaltrials.gov/ct2/show/NCT00427609

Apr 21st, 2015 - Psoriasis is a chronic, inflammatory skin disorder most commonly manifested by well-demarcated, erythematous and/or scaling plaques on the elbows, knees, scalp, and trunk. Psoriasis is a common disease with overall incidence of 1-3% of the general...

Effect of Atopic Diathesis as Assessed by Serum Th1/Th2 Cytokine Profile on Clinical Manifestation of Psoriasis
https://clinicaltrials.gov/ct2/show/NCT00372580

Sep 7th, 2006 - It has been suggested that psoriasis is not a homogeneous disease. It is a constellation of diseases sharing similar pathologic findings. Clinical distinct entities of psoriasis include pustular psoriasis, guttate psoriasis, psoriasis vulgaris, er...

see more →

News  15 results

COVID-19 infection linked to risk of cutaneous autoimmune and vascular diseases
https://www.mdedge.com/dermatology/article/253200/autoimmune-diseases/covid-19-infection-linked-risk-cutaneous-autoimmune
Doug Brunk

Mar 26th, 2022 - BOSTON – Following infection with SARS-CoV-2 infection, patients between the ages of 18 and 65 were at a significantly increased for developing certain cutaneous autoimmune and vascular diseases. This predominately favored systemic disease states.

Guttate Psoriasis Following COVID-19 Infection
https://www.mdedge.com/dermatology/article/251436/psoriasis/guttate-psoriasis-following-covid-19-infection
Rucha P. Janodia, BA, Erine A. Kupetsky, DO, MSc

Feb 4th, 2022 - Psoriasis is an inflammatory skin condition affecting 1% to 5% of the world population. 1 Guttate psoriasis is a subgroup of psoriasis that most commonly presents as raindroplike, erythematous, silvery, scaly papules.

Cutaneous Chaetomium globosum Infection in a Vedolizumab-Treated Patient
https://www.mdedge.com/dermatology/article/244500/infectious-diseases/cutaneous-chaetomium-globosum-infection-vedolizumab
Morgan Cronin, MD, Timothy G. Berger, MD et. al.

Aug 20th, 2021 - To the Editor: Broader availability and utilization of novel biologic treatments has heralded the emergence of unusual infections, including skin and soft tissue infections. These unusual infections may not be seen in clinical trials due to their.

Apremilast Uses and Relevance to the Military
https://www.mdedge.com/dermatology/article/238305/psoriasis/apremilast-uses-and-relevance-military
Nathanael E. Hathaway, MD, Willis Hughes Lyford, MD

Apr 7th, 2021 - Apremilast is a small-molecule biologic approved by the US Food and Drug Administration (FDA) for use in plaque psoriasis, psoriatic arthritis, and Behçet disease. 1-6 Although apremilast is seemingly a less favorable choice for treating psoriasis.

Fast Five Quiz: Can You Recognize Different Types of Psoriasis?
https://reference.medscape.com/viewarticle/912181_4

Aug 11th, 2020 - Figure 3. Guttate psoriasis rash on back. Although guttate psoriasis is uncommon in the United States (< 2% of the psoriasis population), its prevalence varies internationally (from 1.6% to 44%), depending on the distribution of streptococcus epid...

see more →